March 7, 2017 / 1:06 PM / 6 months ago

BRIEF-Helix Biopharma says Heman Chao to become CEO

March 7 (Reuters) - Helix Biopharma Corp

* Announces strategic management changes

* Dr. Sven Rohmann, CEO and chairman of company, will be stepping down from his position as chief executive officer

* Heman Chao will assume position of chief executive officer Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below